Professor, Pediatrics, University of Alabama School of Medicine
Pediatric Infectious Disease
Dr. David W. Kimberlin, MD
|
|
Give Review
David Kimberlin works in the field of Pediatric Infectious Disease. He researched medicine at University of Texas Southwestern Medical School. He has 1 awards "Fellow (FAAP)". David Kimberlin is a published doctor and has 74 publications published. The lastest was: 'Human herpesvirus-6: neurologic implications of a newly-described viral pathogen.'
Publications
- Update From the Advisory Committee on Immunization Practices.
- A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis.
- Quantitative Herpes Simplex Virus Concentrations in Neonatal Infection.
- Neonatal herpes simplex virus infection: epidemiology and treatment.
- Valganciclovir for symptomatic congenital cytomegalovirus disease.
- Preventing Herpes Simplex Virus in the Newborn.
- Mother-to-Child Transmission of Herpes Simplex Virus.
- Management of neonatal herpes simplex virus infection and exposure.
- RSV Immunoprophylaxis: Does the Benefit Justify the Cost?
- The Scarlet H.
- Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza.
- Maternal and neonatal herpes simplex virus infections.
- Antiviral therapy for cytomegalovirus infections in pediatric patients.
- Pharmacotherapy of recurrent respiratory papillomatosis.
- Antiretroviral pharmacokinetics in the paediatric population: a review.
- Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients.
- Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis.
- Herpes simplex virus infections of the central nervous system.
- Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospect...
- Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.
- Molecular diagnosis of viral infections of the central nervous system.
- Neonatal herpes simplex infection.
- Clinical practice. Genital herpes.
- Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.
- Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis.
- Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the...
- Neonatal herpes: what have we learned.
- Herpes simplex encephalitis: children and adolescents.
- Antiviral therapies in children: has their time arrived?
- Neonatal HSV infections: the global picture.
- Diagnosis of herpes simplex virus infections of the CNS.
- Herpes simplex virus infections in neonates and early childhood.
- Diagnosis of herpes simplex virus in the era of polymerase chain reaction.
- Herpes simplex virus infections of the newborn.
- Varicella-zoster vaccine for the prevention of herpes zoster.
- Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovir...
- Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.
- The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus.
- Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.
- Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.
- Targeted antiviral prophylaxis with oseltamivir in a summer camp setting.
- Oseltamivir dosing for influenza infection in premature neonates.
- Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment.
- Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease.
- When should you initiate acyclovir therapy in a neonate?
- Control of varicella disease, version 2.0.
- Oral acyclovir suppression and neurodevelopment after neonatal herpes.
- Determination of appropriate dosing of influenza drugs in pediatric patients.
- Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation.
- Antiviral resistance--an emerging problem.
- Molecular mechanisms of antiviral resistance.
- Assays for antiviral drug resistance.
- Models of antiviral resistance.
- Antiviral resistance in clinical practice.
- Research initiatives in studies of antiviral resistance and consensus points and recommendations.
- Protein synthesis-dependent induction of interleukin-1 beta by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cells.
- Modulation of expression of genes involved in the inflammatory response by lipopolysaccharide and temperature in cultured human astroglial cells.
- Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Dis...
- Treatment of viral infections during pregnancy and the neonatal period.
- Antiviral resistance: mechanisms, clinical significance, and future implications.
- Rubella immunization.
- Human herpesviruses 6 and 7: identification of newly recognized viral pathogens and their association with human disease.
- Herpes simplex viruses.
- Human herpesvirus-6: neurologic implications of a newly-described viral pathogen.
- Viral encephalitis.
- Juvenile onset recurrent respiratory papillomatosis: possibilities for successful antiviral therapy.
- Advances in the treatment of neonatal herpes simplex infections.
- Natural history of neonatal herpes simplex virus infections in the acyclovir era.
- Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.
- Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies.
- Herpes simplex virus, meningitis and encephalitis in neonates.
- Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.
- The effect of the increasing prevalence of maternal obesity on perinatal morbidity.
Schools
University of Texas Southwestern Medical Center At Dallas
Chldns Mc Dallas
Birmingham Mc
University Tex Sw
Doctors Specialties
- Pediatric Infectious Disease Medicine
- Pediatric Infectious Disease
Accepted Insurances
Awards
- Fellow (FAAP)
Education
-
University of Texas Southwestern Medical School
Hospital
-
University of Alabama Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Robert F. Pass, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennie Andresen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jerry J. Eller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sergio B. Stagno, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard J. Whitley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin A. Cassady, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marilyn J. Crain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suresh B. Boppana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William S. Foshee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Masako Shimamura, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shannon A. Ross, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Akpobome P. Wodi, MB
This Doctor is OpenDoctor Recommended.
|